<DOC>
	<DOCNO>NCT02225600</DOCNO>
	<brief_summary>The study examine behavioral pattern underlie neural correlate distinguish patient borderline personality disorder ( BPD ) healthy subject participate two-person trust game determine whether administration intranasal oxytocin ( OT ) normalize trust game performance concomitant neural processing BPD group .</brief_summary>
	<brief_title>The Effect Oxytocin Administration Interpersonal Cooperation Borderline Personality Disorder Patients Healthy Adults</brief_title>
	<detailed_description>This pilot study support submission larger-scale federally fund study . The study design develop new strategy treat severe interpersonal dysfunction borderline personality disorder ( BPD ) model interpersonal disturbance BPD laboratory , identify neural correlate determine whether social neuropeptide , oxytocin , ameliorate interpersonal dysfunction . The study examine behavioral pattern underlie neural correlate distinguish patient borderline personality disorder ( BPD ) healthy subject participate two-person trust game determine whether administration intranasal oxytocin ( OT ) normalize trust game performance concomitant neural processing BPD group . The specific aim study : 1 ) determine whether BPD patient healthy control ( HC ) differ pattern invest trustee trustee behave benevolently malevolently towards suddenly become malevolent period benevolence ( vice-versa ) multi-round economic exchange game ( `` The Trust Game '' ) , 2 ) determine effect upon behavior administration 40 IU intranasal oxytocin relative placebo BPD subject HC 's engage Trust Game .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Personality Disorders</mesh_term>
	<mesh_term>Borderline Personality Disorder</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>BPD subject meet criterion DSMIV Borderline Personality Disorder . 18 55 year old Healthy control free lifetime DSMIV Axis I Axis II diagnosis . However , avoid group HC 's highly groom unrepresentative general population subject meet criterion past Axis I diagnosis adjustment , dysthymic , depressive NOS disorder , specific phobia , sleep disorder exclude . Subjects exclude nonIV substance abuse disorder 6 month prior enrollment . All subject free psychotropic medication 2 week ( 6 week fluoxetine ) . Subjects may enrol psychotherapy . BPD subject meeting DSMIV criterion past present bipolar I disorder , schizophrenia , schizoaffective disorder , substance dependence , head trauma , CNS neurological disease , seizure disorder current major depression . Since depression commonly associate BPD , stringent depression exclusion criterion would yield clinically atypical BPD sample . For reason , BPD patient Axis I depressive disorder major depression past history major depression exclude . Substance abuse disorder prior 6 month Significant medical illness Pregnancy Metallic foreignbodies contraindicate MRI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Borderline Personality Disorder</keyword>
	<keyword>BPD</keyword>
	<keyword>Intranasal oxytocin</keyword>
</DOC>